跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube - TGA Drug Approval Details
Approvals
/
TGA
/
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
Approved
STANDARD
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
MC2 Therapeutics Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
057608535ba2148d
Company
MC2 Therapeutics Pty Ltd
Type
Standard
Approval Details
Approval Id
057608535ba2148d
Product Name
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
Artg Id
427184
Artg Name
WYNZORA 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g cream tube
Sponsor
MC2 Therapeutics Pty Ltd
Company Detail Path
/organization/mc2-therapeutics-pty-ltd
Artg Date
2024-11-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
057608535ba2148d
Type
Standard
Back to TGA Approvals